Increasing global travel and rapid viral evolution continues to fuel annual influenza epidemics, which are constantly mutating.
Widespread public health campaigns to vaccinate are able to prevent some infections, but the efficacy of the vaccine varies by year depending on the dominant strains of the year.
An estimated 45 million Americans were infected by the influenza virus in the 2017-2018 season resulting in over 800,000 hospitalizations and 61,000 deaths.
The Seraph Research team are developing new treatments to reduce the severity and length of infection and help prevent the high number of deaths each year.
Our scientific team pursues innovative and revolutionary prevention and treatment strategies, with the goal of creating a cure.
Groundbreaking research and development, designed to prevent and eradicate the coronavirus and all SARS related virus mutations.
Spearheading medical scientific research efforts using novel and proprietary mechanism of action, that directly targets the virus at its source.
For research updates and news, please enter your email address in the field below.
©2020 | Seraph Research Institute
Individualized Research Team Give